These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7737140)

  • 1. Overview of mutation assays in transgenic mice for routine testing.
    Gorelick NJ
    Environ Mol Mutagen; 1995; 25(3):218-30. PubMed ID: 7737140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine.
    Nicolette J; Murray J; Sonders P; Kondratiuk A; Crosby M
    Environ Mol Mutagen; 2021 Jan; 62(1):4-17. PubMed ID: 32951273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian cell gene mutation assays working group report.
    Aaron CS; Bolcsfoldi G; Glatt HR; Moore M; Nishi Y; Stankowski L; Theiss J; Thompson E
    Mutat Res; 1994 Jun; 312(3):235-9. PubMed ID: 7514737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics.
    Brambilla G; Martelli A
    Pharmacol Res; 2009 Jul; 60(1):1-17. PubMed ID: 19427580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of transgenic mutational test systems in risk assessment of carcinogens.
    Schmezer P; Eckert C; Liegibel UM; Klein RG; Bartsch H
    Arch Toxicol Suppl; 1998; 20():321-30. PubMed ID: 9442305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the genotoxicity of marketed pharmaceuticals.
    Snyder RD; Green JW
    Mutat Res; 2001 May; 488(2):151-69. PubMed ID: 11344042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of predictivity of volatile organic compounds carcinogenicity and mutagenicity by freeware in silico models.
    Guerra LR; de Souza AMT; Côrtes JA; Lione VOF; Castro HC; Alves GG
    Regul Toxicol Pharmacol; 2017 Dec; 91():1-8. PubMed ID: 28970106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro testing for carcinogens and mutagens.
    Santella RM
    Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unique role of rodents in the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicity.
    Kamber M; Flückiger-Isler S; Engelhardt G; Jaeckh R; Zeiger E
    Mutagenesis; 2009 Jul; 24(4):359-66. PubMed ID: 19447896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro mammalian cell mutation assays based on transgenic reporters: A report of the International Workshop on Genotoxicity Testing (IWGT).
    White PA; Luijten M; Mishima M; Cox JA; Hanna JN; Maertens RM; Zwart EP
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403039. PubMed ID: 31699347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.